Salesforce Friends ...
Health Care: Drugs
Columbia Laboratories Inc. (CBRX: NASDAQ)
$0.68 0.00 | 0.00%
06/04/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 20.53M | -21.83M | -21.87M | -14.08M |
| Operating Gains/Losses | -2.53M | 5.16M | 0.00 | 3.05K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -562.00K | 62.53K | -700.57K | 244.45K |
| (Increase) Decrease in Inventories | -1.40M | -94.80K | -237.30K | -76.92K |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 9.18K | 0.00 |
| (Decrease) Increase In Payables | -1.87M | 1.73M | 1.58M | -130.48K |
| (Decrease) Increase In Other Current Liabilities | -1.84M | -1.87M | -1.61M | -1.28M |
| (Increase) Decrease In Other Working Capital | 144.86K | 124.00K | 0.00 | -383.32K |
| Other Non-Cash Items | -13.71M | 1.64M | 5.14M | 5.20M |
| Net Cash From Continuing Operations | -1.34M | -9.72M | -9.06M | -5.14M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -1.34M | -9.72M | -9.06M | -5.14M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -1.31M | -42.39K | -49.85K | -375.93K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 3.10M | 35.24M | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -13.31M | 35.20M | -49.85K | -375.93K |
| Issuance of Debt | 0.00 | 15.00M | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 3.30M | 11.72M | 11.46M | 4.69M |
| Repayment of Long-Term Debt | 0.00 | -42.16M | 0.00 | 0.00 |
| Repurchase of Capital Stock | -125.38K | -3.12M | -91.58K | -135.20K |
| Payment of Cash Dividends | -30.00K | -30.00K | -32.19K | -55.14K |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | -3.54M |
| Net Cash From Financing Activities | 3.14M | -18.59M | 11.33M | 959.19K |
| Effect of Exchange Rate Changes | -7.73K | -15.48K | 33.22K | -171.21K |
| Net Change in Cash & Cash Equivalents | -11.52M | 6.87M | 2.26M | -4.72M |
Portfolios with CBRX
- Portfolio NameUser Type
- UserMy Portfolio
- Contributor11 Stocks Under $4 With Upside
- Usermincronn Portfolio 1
- Usercscob Portfolio 1
- Userpharmer
- UserSUPRATRADE 2307070204
- UserSUPRATRADE VIRTUAL SKY
- Userstock fund
- UserBob700 Portfolio 1
- UserDunroamins
Latest CBRX Headlines from TheStreet
- A Classic Biotech Long Shot 04.05.12 | 09:04 am
- Columbia Stock Gaps Down On Today's Open (CBRX) 02.27.12 | 08:02 am
- These Drugs Stocks Will Win FDA Approval 02.16.12 | 12:02 pm
- Columbia Stock Soars (CBRX) 01.24.12 | 12:01 pm
- Columbia Stock Gaps Down On Today's Open (CBRX) 01.23.12 | 08:01 am
- Columbia Stock Gaps Up On Today's Open (CBRX) 01.18.12 | 08:01 am
- Columbia Laboratories Inc. Stock Upgraded (CBRX) 08.10.11 | 07:08 am
- 11 Stocks Under $4 With Upside: Analysts 05.11.11 | 12:05 pm
- Biotech Calendar: Key Dates for May 05.02.11 | 09:05 am
- Columbia Stock Falls On Unusually High Volume (CBRX) 04.06.11 | 02:04 pm
Press Releases for CBRX
- Columbia Laboratories Reports First Quarter 2012 Financial Results - Business Wire 05.04.12 | 06:05 am
- Columbia Laboratories Hires Cowen And Company To Assist In Evaluating Potential Strategic Transactions - Business Wire 03.13.12 | 06:03 am
- Columbia Laboratories Reports Fourth Quarter And Year-End 2011 Financial Results - Business Wire 03.08.12 | 06:03 am
- Columbia Laboratories Receives Nasdaq Minimum Bid Price Non-compliance Letter - Business Wire 03.06.12 | 04:03 pm
- Columbia Laboratories Announces 42% Workforce Reduction - Business Wire 03.01.12 | 04:03 pm
- Columbia Laboratories To Discuss Fourth Quarter And Year-End 2011 Financial Results On March 8, 2012, Conference Call - Business Wire 03.01.12 | 06:03 am
- Columbia Laboratories Will Present March 5th At Cowen And Company Health Care Conference - Business Wire 02.29.12 | 06:02 am
- Faruqi & Faruqi, LLP Announces Investigation Of Columbia Laboratories Inc. - PR Newswire 02.09.12 | 11:02 am
- The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Columbia Laboratories Inc. Of Class Action Lawsuit And The Deadline Of April 2, 2012 To Seek A Lead Plaintiff Position - Business Wire 02.02.12 | 02:02 pm
- Bronstein, Gewirtz & Grossman, LLC Investigates Columbia Laboratories, Inc. - Business Wire 01.23.12 | 10:01 am
Partner Headlines for CBRX
- Bio-Pharma Drug Approval Watch List: Final Results Plus One To Watch - Seeking Alpha 03.30.12 | 09:03 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- Market Losers - Benzinga 01.23.12 | 01:01 pm
- Columbia Labs Plummet after Recommendation Denial by FDA - Benzinga 01.23.12 | 09:01 am
- FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length - Benzinga 01.20.12 | 04:01 pm
- Watson Pharma and Columbia Labs Plunge on Proposed FDA Review - Benzinga 01.17.12 | 01:01 pm
- Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA - Benzinga 11.10.11 | 09:11 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 09.16.11 | 09:09 am
- Watson to Market Antares' OAB Drug - Analyst Blog - Zacks 07.12.11 | 10:07 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
